Published in Hypertension on June 09, 2014
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol (2015) 0.92
Preeclampsia and Pregnancy-Related Hypertensive Disorders. Hypertension (2015) 0.81
Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy. Am J Physiol Heart Circ Physiol (2015) 0.78
Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat. J Pharmacol Exp Ther (2014) 0.77
Down but not out: an emerging role for the B-type endothelin receptor in placental ischemia-induced hypertension. Hypertension (2014) 0.76
Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia. Int J Mol Sci (2017) 0.75
Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets (2015) 0.75
Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol (2016) 0.75
Angiogenic Imbalance and Diminished Matrix Metalloproteinase-2 and -9 Underlie Regional Decreases in Uteroplacental Vascularization and Feto-placental Growth in Hypertensive Pregnancy. Biochem Pharmacol (2017) 0.75
Decreased Homodimerization and Increased TIMP-1 Complexation of Uteroplacental and Uterine Arterial Matrix Metalloproteinase-9 during Hypertension-in-Pregnancy. Biochem Pharmacol (2017) 0.75
Increased Vascular and Uteroplacental Matrix Metalloproteinase-1 and -7 Levels and Collagen I Deposition in Hypertension-in-Pregnancy. Role of TNF. Am J Physiol Heart Circ Physiol (2017) 0.75
Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Prog Mol Biol Transl Sci (2017) 0.75
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Preeclampsia: recent insights. Hypertension (2005) 2.98
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension (2007) 2.53
Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev (2011) 2.22
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 2.00
Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension (2005) 1.95
Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag (2011) 1.86
EDHF: an update. Clin Sci (Lond) (2009) 1.67
Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest (2000) 1.65
Fetal programming of hypertension. Am J Physiol Regul Integr Comp Physiol (2006) 1.63
Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension (2006) 1.58
Vascular endothelin in hypertension. Vascul Pharmacol (2005) 1.52
Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension (2001) 1.51
Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension (2009) 1.49
Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens (2009) 1.41
Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension (2000) 1.37
Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol (2002) 1.36
Hemodynamic changes in pregnancy. Semin Perinatol (2000) 1.35
Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol (2012) 1.25
Vascular biology of endothelin. J Cardiovasc Pharmacol (1998) 1.24
Regional variation in resistance artery diameter responses to alpha-adrenergic stimulation during pregnancy. Am J Physiol (1993) 1.10
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol (2011) 1.04
Endothelin-1--induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAPK-independent [Ca(2+)](i) sensitization pathways. Hypertension (2002) 1.01
Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2002) 0.99
Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats. Hypertension (2013) 0.96
Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. Hypertension (2009) 0.95
Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Hypertension (2013) 0.94
Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol (2005) 0.91
Endothelin-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension (2000) 0.89
Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol (2010) 0.88
Endothelin-1 and -3 cause endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol (1993) 0.87
Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. Hypertension (1995) 0.85
Influence of ET(B) receptor antagonism on pregnancy outcome in rats. J Soc Gynecol Investig (2001) 0.85
Vascular biology of endothelin signal transduction. Clin Exp Pharmacol Physiol (1999) 0.85
Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications. Curr Opin Nephrol Hypertens (2012) 0.83
Increased myogenic responses of resistance-sized mesenteric arteries after reduced uterine perfusion pressure in pregnant rats. Hypertens Pregnancy (2010) 0.82
Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.82
Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats. Br J Pharmacol (2013) 0.82
Role of endothelin and inflammatory cytokines in pre-eclampsia - A pilot North Indian study. Am J Reprod Immunol (2011) 0.81
Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats. J Cell Physiol (2014) 0.77
Hypotensive effect of endothelin-1 in nitric oxide-deprived, hypertensive pregnant rats. Am J Hypertens (2001) 0.77
Endothelin-1 causes a biphasic response in systemic vasculature and increases myocardial contractility in conscious rabbits. J Cardiovasc Pharmacol (1994) 0.77